- Home
- AUPH vs BLMN Comparison
AUPH vs BLMN Comparison
Compare AUPH & BLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- BLMN
- Stock Information
- Founded
- AUPH 1993
- BLMN 1988
- Country
- AUPH Canada
- BLMN United States
- Employees
- AUPH N/A
- BLMN N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- BLMN Restaurants
- Sector
- AUPH Health Care
- BLMN Consumer Discretionary
- Exchange
- AUPH Nasdaq
- BLMN Nasdaq
- Market Cap
- AUPH 1.1B
- BLMN 1.4B
- IPO Year
- AUPH 1999
- BLMN 2012
- Fundamental
- Price
- AUPH $8.01
- BLMN $12.62
- Analyst Decision
- AUPH Strong Buy
- BLMN Hold
- Analyst Count
- AUPH 3
- BLMN 11
- Target Price
- AUPH $10.33
- BLMN $16.30
- AVG Volume (30 Days)
- AUPH 1.3M
- BLMN 1.7M
- Earning Date
- AUPH 02-13-2025
- BLMN 02-21-2025
- Dividend Yield
- AUPH N/A
- BLMN 7.59%
- EPS Growth
- AUPH N/A
- BLMN N/A
- EPS
- AUPH N/A
- BLMN N/A
- Revenue
- AUPH $220,361,000.00
- BLMN $4,547,161,000.00
- Revenue This Year
- AUPH $36.97
- BLMN N/A
- Revenue Next Year
- AUPH $16.43
- BLMN N/A
- P/E Ratio
- AUPH N/A
- BLMN N/A
- Revenue Growth
- AUPH 38.72
- BLMN N/A
- 52 Week Low
- AUPH $4.71
- BLMN $11.03
- 52 Week High
- AUPH $10.67
- BLMN $30.13
- Technical
- Relative Strength Index (RSI)
- AUPH 45.28
- BLMN 54.22
- Support Level
- AUPH $7.67
- BLMN $12.01
- Resistance Level
- AUPH $8.54
- BLMN $12.97
- Average True Range (ATR)
- AUPH 0.27
- BLMN 0.52
- MACD
- AUPH 0.03
- BLMN 0.12
- Stochastic Oscillator
- AUPH 43.62
- BLMN 80.77
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.
About BLMN Bloomin' Brands Inc.
Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.